Cizumab 400 mg Bevacizumab Injection – Overview
Cizumab 400 mg is a pharmaceutical injection containing Bevacizumab, a monoclonal antibody manufactured by Hetero Healthcare Ltd. Bevacizumab is designed to target and inhibit vascular endothelial growth factor (VEGF), a protein responsible for the growth of blood vessels that supply tumors. It is used in combination with chemotherapy for the treatment of various cancers, including colorectal, lung, kidney, and brain cancers. Cizumab 400 mg is produced under strict quality standards to ensure effectiveness and patient safety.
Benefits of Cizumab 400 mg Injection:
- VEGF Inhibition: Helps slow or stop the growth of blood vessels that feed tumors.
- Combination Therapy: Used alongside chemotherapy to improve treatment outcomes.
- Versatile Application: Prescribed for multiple cancers, including colorectal, lung, and kidney cancer.
- Quality Manufacturing: Produced under stringent quality control by Hetero Healthcare Ltd.
- Secure Packaging: Ensures product stability and effectiveness during storage and transport.
Specification/Additional Details
- Strength: 400 mg
- Packaging Type: Vial
- Packaging Size: 16 ml per vial
- Brand: Cizumab
- Manufactured By: Hetero Healthcare Ltd
- Country of Origin: India
Reviews
There are no reviews yet.